SEC Filing Details

SEC Filing Details

Document Details

Form
SC 13G
Filing Date
Jan 17, 2024
Document Date
Jan 17, 2024
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
Other
Company
ReShape Lifesciences
Issuer
RESHAPE LIFESCIENCES INC.
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE